Domino supports manufacturers for 2D Codes

The use of 2D codes has increased in the pharma market

0
279
Domino is supporting the pharma drug manufacturers for 2D codes
Domino is supporting the pharma drug manufacturers for 2D codes Photo: Domino

Increasing demand for product data is driving the need for 2D codes, which are expected to join linear barcodes at the point of sale within the next five years. The growth in 2D codes can present huge opportunities for brands, who must now ensure that their coding and marking capabilities are designed to work in this data-rich world. 

Domino to fulfill regulatory serialization requirements through 2D codes

Lee Metters, Group business development director, Domino
Lee Metters, Group business development director, Domino

Lee Metters, Group business development director, Domino Printing Sciences (Domino), comments, “Society has woken up to using 2D codes on a global level. Consumers are now more adept at using 2D codes due in part to the normalization of 2D scanning facilitated by the Covid-19 pandemic.

“In addition, we have already seen 2D codes used, with great success, in the pharma market, with legislation including the EU’s Falsified Medicines Directive (FMD), the United States’ federal Drug Supply Chain Security Act (DSCSA), and Russia’s Chestny ZNAK regulation requiring item-level serialization of products through 2D codes.

“This success can now be replicated in other industries to bring a greater wealth of product data to consumers, retailers, and everyone involved within global supply chains.”

As a world-leading coding and marking provider with expertise helping brands to fulfill regulatory serialization requirements through 2D codes, and long-standing partnerships with key industry associations, Domino is well-placed to help manufacturers prepare for this new dimension in barcodes.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here